1Belmont HM. Treatment of ANCA-associated systemic vasculitis [J]. Bull NYU Hosp Jt Dis,2006,64(1-2):60-66.
2Yu F, Huang JP, Zou WZ, et al. The clinical features of antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children [J]. Pediatr Nephrol, 2006,21(4) :497-502.
3Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy [ J ]. Allergol Int, 2007,56 (2) : 87-96.
4Martinez V,Cohen P,Pagnoux C, etal. IntravenOus imnaunoglobulins for relapses of systemic vasculitides associated with antinentrophil cytoplasmic autoantibodies:resuhs of a multicenter, prospective,open-label study of twenty-two patients [J]. Arthritis Rheum,2008,58(1 ) :308-317.
5Bourgarit A, Le Toumelin P, Pagnoux C, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients [J]. Medicine (Bahimore),2005,84(5): 323-330.
